In this review:
Highlights from the Consensus Panel
Reducing the incidence of chemotherapyrelated VTE
Tamoxifen metabolites predict long-term outcome?
Optimal adjuvant therapy for T1ab, N–, HER2+ disease
DFS data with extended letrozole in early-stage disease
Metformin may improve PFS in HR+, HER2– disease
Timing of ovarian suppression in premenopausal ER+ disease
MONALEESA-2 data support ribociclib, regardless of prior treatment
An analysis of the benefit of the Recurrence Score in N+ disease
Data on breast cancer diagnosed during pregnancy
Listening to music alleviates anxiety during chemotherapy
Please login below to download this issue (PDF)